Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products in Europe, the United States, and internationally. It develops MOB-015, which has completed Phase III clinical trial for the treatment of nail fungus. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was incorporated in 2006 and is headquartered in Bromma, Sweden.
Moberg Pharma Dividend Announcement
• Moberg Pharma announced a annually dividend of kr4.65 per ordinary share which will be made payable on . Ex dividend date: 2019-11-04
• Moberg Pharma's trailing twelve-month (TTM) dividend yield is -%
Moberg Pharma Dividend History
| Ex-Div date | Dividend amount | Dividend type | Pay date |
|---|---|---|---|
| 2019-11-04 | kr4.65 | annually |
Moberg Pharma Dividend per year
Moberg Pharma Dividend Yield
Moberg Pharma current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Moberg Pharma stock? Use our calculator to estimate your expected dividend yield:
Moberg Pharma Financial Ratios
P/E ratio-47.87
PEG ratio2.19
P/B ratio0.94
ROE-2.38%
Payout ratio0.00%
Current ratio22.52
Quick ratio22.03
Cash Ratio21.67
Moberg Pharma Dividend FAQ
Does Moberg Pharma stock pay dividends?
Moberg Pharma does not currently pay dividends to its shareholders.
Has Moberg Pharma ever paid a dividend?
No, Moberg Pharma has no a history of paying dividends to its shareholders. Moberg Pharma is not known for its dividend payments.
Why doesn't Moberg Pharma pay dividends?
There are several potential reasons why Moberg Pharma would choose not to pay dividends to their shareholders:
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Moberg Pharma ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Moberg Pharma has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Moberg Pharma a dividend aristocrat?
Moberg Pharma is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Moberg Pharma a dividend king?
Moberg Pharma is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Moberg Pharma a dividend stock?
No, Moberg Pharma is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Moberg Pharma stocks?
To buy Moberg Pharma you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.
Place an order: Use the brokerage's trading platform to place an order to buy Moberg Pharma stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
Place an order: Use the brokerage's trading platform to place an order to buy Moberg Pharma stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.